| Date | Title | Description |
| 19.12.2025 | Adara Ventures: Year in Review 2025
Highlights from 2025
Launching AV4: Our fourth flagship fund
First investments from AV4
Our 20th Anniversary and Investor Conference 2025
Joining the NVIDIA Incepti... | As 2025 comes to a close, we wanted to take a moment to reflect on an especially meaningful year at Adara Ventures.
This year, we celebrated major milestones, including the first close of our fourth flagship fund (AV4) and a special Investo... |
| 02.12.2025 | Aidoc Partners with NVIDIA MONAI to Scale Open-Source Clinical AI | What You Should Know:
– Aidoc, a leader in clinical AI, has expanded its aiOS™ (AI Operating System) through a collaboration with NVIDIA MONAI and a new partnership with Quibim to solve the “last mile” deployment challenge for imaging AI.
–... |
| 18.09.2025 | Capital meets care: 10 venture capital firms transforming healthcare across Europe | Venture capital remains one of the cornerstones of Europe’s innovation landscape, fuelling the growth of startups across every sector. In our last list, we spotlighted 15 VC firms focused on sustainability, underlining how investors are sha... |
| 16.09.2025 | Spanish cancer startup Highlight Therapeutics closes €15 million round to further skin tumour treatment | Valencia’s Highlight Therapeutics, a biopharmaceutical company focused on the development of next-generation immunotherapies, has raised €15 million aimed at strengthening their position in the treatment of skin tumours and accelerating its... |
| 18.03.2025 | The Rise of European Venture Capital: A New Era of Investment | The European venture capital landscape is evolving. Two firms, Adara Ventures and bd-capital, are leading the charge. They are not just raising funds; they are shaping the future of investment in technology and mid-market businesses. Adara ... |
| 17.03.2025 | Adara Ventures announces first close of €100 million Adara Ventures IV Fund | Adara Ventures, the Madrid-based VC firm specialising in early-stage DeepTech investments, today announced the first close of its fourth flagship fund, AV4, targeting €100 million in capital commitments.
This new fund reinforces Adara’s com... |
| 03.02.2025 | Quibim: Imaging Biomarker Company Raises $50 Million (Series A) | Quibim, a leading health technology company pioneering imaging biomarkers for precision medicine, announced the closing of its $50 million Series A funding round. And the company has experienced remarkable growth in the number of patients a... |
| 29.01.2025 | Quibim's Leap into the U.S. Market: A $50M Investment in Precision Medicine | In the world of health technology, precision is paramount. Quibim, a Valencia-based healthtech company, has just secured a significant $50 million in Series A financing. This funding is not just a number; it’s a lifeline aimed at transformi... |
| 29.01.2025 | Quibim Announces $50 Million in Series A Financing to Revolutionize Precision Medicine with AI-Powered Imaging Biomarkers | Quibim, a leading healthtech company pioneering the use of imaging biomarkers for precision medicine, announced today the close of its $50 million Series A financing. The company has experienced remarkable growth in the number of patients a... |
| 29.01.2025 | Quibim Secures $50M to Advance AI-Powered Imaging Biomarkers for Precision Medicine | What You Should Know:
– Quibim, a leading healthtech company pioneering the use of imaging biomarkers for precision medicine, announced today the close of its $50 million Series A financing.
– The company has experienced remarkable growth i... |
| 28.01.2025 | Quibim secures $50m Series A to fuel AI-powered medical imaging solutions for better disease detection | We are excited to share the news that Adara portfolio company Quibim, a leading digital health tech company pioneering the use of imaging biomarkers for precision medicine, has closed $50 million in a Series A investment round led by Asabys... |
| 28.01.2025 | Quibim Raises $50M in Series A Financing | Quibim, a Valencia, Spain-based healthtech company for precision medicine, raised $50M in funding.
The round was led by Asabys (through its fund Sabadell Asabys II) and Buenavista Equity Partners (through the BHG I fund, created in partners... |
| 28.01.2025 | Quibim, a startup using AI imaging to aid in disease detection, raises $50M
Your vote of support is important to us and it helps us keep the content FREE.
One click below supports our mission to provi... | A Spanish artificial intelligence startup called Quibim S.L. said today it has closed on a $50 million early-stage funding round to help accelerate the development of its foundational models for medical imaging.
Today’s Series A round was l... |
| 28.01.2025 | HealthTech Quibim’s vision for human digital twins gets €47.9M boost | Quibim, a Valencia-based HealthTech company innovating the use of imaging biomarkers for precision medicine, announced today the close of its €47.9 million Series A financing in order establish US presence.
The financing was led by Asabys (... |
| 22.07.2024 | Summer 2024 Review |
As we head into the second half of 2024, we wanted to reflect on the key moments from the past few months: celebrating new investments, team promotions, and impressive growth stories from our across portfolio.
We have completed the final i... |
| 13.03.2024 | Enhancing Prostate Cancer Screening: AI, Imaging and Clinical Innovations, Upcoming Webinar Hosted by Xtalks | www.quibim.com
In this free webinar, learn about the evolution of prostate cancer screening and the shift to magnetic resonance imaging (MRI)-based diagnostic tools for more accurate screening. Attendees will learn about the contribution of... |
| 06.10.2023 | Leadwind anuncia sus primeras inversiones con $250 millones de capital fresco para apoyar una nueva era de empresas tecnológicas en el sur de Europa y Latinoamérica | 06/10/2023
Nota de prensa
LEADWIND ANUNCIA SUS PRIMERAS INVERSIONES CON $250 MILLONES DE CAPITAL FRESCO PARA APOYAR UNA NUEVA ERA DE EMPRESAS TECNOLÓGICAS EN EL SUR DE EUROPA Y LATINOAMÉRICA
Tras más de un año de operaciones y después de... |
| 05.10.2023 | Leadwind fund closes with a $250M commitment and first five investments | Spanish investment fund Leadwind (from K Fund) has announced its final close with commitments up to $250 million. The initial aim was €200 million. Investors included in the gathering are Catalana Occidente, Estrella Galicia, Proeduca Summa... |
| 29.05.2023 | Quibim, a Company Leveraging Artificial Intelligence to Improve Cancer Diagnostics, Makes Key Move Into U.S. By Hiring Boston-Based Chief Medical Officer | Catching cancer earlier and achieving more accurate initial diagnostics are two of the key benefits of breakthrough artificial intelligence technology that a European company is now bringing to U.S. patients. For Quibim, a leading provider ... |
| 18.11.2021 | Perspectives: Investing in the infrastructure shaping Digital Health | Over the coming months, we’ll be taking a deeper dive into sectors, trends, and technologies that we believe represent compelling investment opportunities. In this edition, Partner Rocío Pillado walks us through Adara’s perspective on Digit... |
| 04.03.2021 | Quibim Receives FDA 510(k) Clearance for qp-Prostate New AI Solution for Prostate MRI Analysis | |
| 04.11.2020 | EIT Health startups see strong Q3 with €72.7 million funding raised | EIT Health-supported startups have reported a successful quarter three in terms of fundraising, with €72.7 million secured.
The 19 startups hail from 10 European countries and will use the funds to further develop their solutions addressin... |
| 02.11.2020 | These 19 European startups backed by EIT Health have raised a total of €72.7M in Q3’20 | Germany, Munich-based European Institute of Innovation & Technology (EIT), EIT Health has announced that its supported startups have reported a successful Q3 in terms of fundraising, with €72.7M secured.
The 19 startups that hail from 1... |
| 20.10.2020 | Applying AI to Radiology to drive ultra accurate disease detection at scale: Why we invested in Quibim | We are excited to announce our recent investment in Quibim, a Digital Health startup from Valencia that provides a quantitative radiology solution for doctors and researchers. We were joined in the €8m fundraising round by Amadeus Capital P... |
| 06.10.2020 | QUIBIM, €8 Millones de ronda | 06/10/2020
Nota de prensa
QUIBIM, €8 MILLONES DE RONDA.
La tecnología de QUIBIM permite obtener la información detallada de las radiografías, fácilmente mediante Inteligencia Artificial.
QUIBIM, liderada por Ángel Alberich, está especia... |
| 23.07.2020 | Valencia-based QUIBIM secures €8 million to detect COVID-19 and other diseases | Spanish medtech company QUIBIM has closed €8 million in new seed round co-led by Amadeus Capital Partners and Adara Ventures. Other participants are-Crista Galli Ventures, Apex Ventures, Partech Ventures and existing shareholders, including... |
| 23.07.2020 | QUIBIM secures €8m for radiology AI platform that detects COVID-19 and other diseases early | Medtech company QUIBIM has closed €8M in new financing in a seed funding round co-led by Amadeus Capital Partners and Adara Ventures, with participation by Apex Ventures, Partech, Crista Galli Ventures and existing shareholders, including T... |
| 23.07.2020 | QUIBIM secures €8m for radiology AI platform that detects COVID-19 and other diseases early | QUIBIM secures €8m for radiology AI platform that detects COVID-19 and other diseases early
23-07-2020
Medtech company QUIBIM has closed €8M in new financing in a seed funding round co-led by Amadeus Capital Partners and Adara Ventures, wit... |
| 22.07.2020 | Quibim secures 8 millions of euro for radiology AI platform that detects Covid-19 and other diseases early | Medtech company Quibim has closed €8M in new financing in a seed funding round co-led by Amadeus Capital Partners and Adara Ventures, with participation by Apex Ventures, Partech, Crista Galli Ventures and existing shareholders, including T... |
| 22.07.2020 | Valencia-based QUIBIM secures €8 million to detect COVID-19 and other diseases early | Spanish medtech company QUIBIM has closed €8 million in new seed round co-led by Amadeus Capital Partners and Adara Ventures, with participation by Apex Ventures, Partech, Crista Galli Ventures and existing shareholders, including Tech Tran... |
| 22.07.2020 | Quibim cierra una ronda de €8M coliderada por AmadeusCP y AdaraVP, acuden también Apex Ventures, Partech, Crista Galli Ventures y los actuales Clave Capital y Angels | 22/07/2020
Nota de prensa
QUIBIM CIERRA UNA RONDA DE €8M COLIDERADA POR AMADEUSCP Y ADARAVP, ACUDEN TAMBIÉN APEX VENTURES, PARTECH, CRISTA GALLI VENTURES Y LOS ACTUALES CLAVE CAPITAL Y ANGELS.
● La inversión permitirá a QUIBIM ampliar la... |
| 22.07.2020 | This Spanish medtech startup helps detect COVID-19 through AI, snaps €8M | Based out of Valencia, QUIBIM is a biotech company dedicated to medical image processing and extraction of imaging biomarkers for the medical imaging workflows. Raised €8M funding
Recently, the company has secured €8M funding in a seed fund... |
| 22.07.2020 | Spanish medtech startup QUIBIM scores €8 million for AI platform that detects diseases, including COVID-19 | Spanish medtech startup QUIBIM, developer of an AI-powered radiology diagnostics platform, has raised €8 million to continue expanding its algorithms, including chest X-ray and CT scan products for detecting COVID-19. The seed funding round... |
| 12.06.2020 | Bridgehead Europe helps 15 more start-ups go abroad | The supported start-ups are working on a range of innovations, like two different solutions for screening and protecting blood samples, a filter that cleans a patient’s blood so that it can be reinfused back into their body, systems for rem... |
| 31.07.2017 | Angels participa en Quibim capitalizando el préstamo que la compañía tenía en Lanzadera | 31/07/2017
Nota de prensa
ANGELS PARTICIPA EN QUIBIM CAPITALIZANDO EL PRÉSTAMO QUE LA COMPAÑÍA TENÍA EN LANZADERA.
La empresa biotecnológica Quibim se refuerza mediante la entrada de Angels – la sociedad de inversión perteneciente a Mari... |
| 28.12.2016 | El fondo Tech Transfer UPV, gestionado por Clave Mayor, invierte €550.000 en Quibim | 28/12/2016
EL FONDO TECH TRANSFER UPV, GESTIONADO POR CLAVE MAYOR, INVIERTE €550.000 EN QUIBIM.
El fondo de capital riesgo Tech Transfer UPV, impulsado por el Consejo Social de la Universitat Politècnica de València y la gestora de capita... |
| - | Quibim | “Leading radiomics company pioneering quantitative imaging biomarkers and medical applications in precision medicine.” |
